The company reported better-than-expected Q4 sales results and issued Q1 and FY22 sales guidance above estimates.
https://www.benzinga.com/wiim/22/02/25768364/hims-hers-health-shares-are-trading-higher-after-the-company-reported-better-than-expected-q4-sales
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.